SLC6A4
Delving into the SLC6A4 Gene: Unraveling Its Significance
Description
The SLC6A4 gene, located on chromosome 17, encodes a protein known as the serotonin transporter (SERT). SERT is responsible for the reuptake of serotonin (5-hydroxytryptamine, 5-HT) from the synaptic cleft back into the presynaptic neuron. This process terminates the synaptic action of serotonin, a neurotransmitter crucial for regulating various physiological and psychological functions.
Associated Diseases
Mutations in the SLC6A4 gene have been linked to several psychiatric and neurological disorders, including:
- Major Depressive Disorder (MDD): Reduced SERT activity is associated with lower serotonin levels, which may contribute to the symptoms of depression, such as low mood, anhedonia, and impaired cognitive function.
- Obsessive-Compulsive Disorder (OCD): Dysregulation of serotonin reuptake by SERT may be involved in the pathophysiology of OCD, characterized by intrusive thoughts and compulsive behaviors.
- Autism Spectrum Disorder (ASD): Alterations in SERT have been implicated in the social and communication difficulties observed in ASD.
- Attention Deficit Hyperactivity Disorder (ADHD): Dysfunctional dopamine and serotonin neurotransmission involving SERT may contribute to the symptoms of ADHD, such as hyperactivity, impulsivity, and attention deficits.
Did you Know ?
Research has shown that approximately 20-30% of antidepressant medications, including selective serotonin reuptake inhibitors (SSRIs), work by modulating the activity of the SLC6A4 gene. This highlights the significant role of SERT in mood regulation and treatment.
